Cargando…

Prediction of survival after eribulin chemotherapy for breast cancer by absolute lymphocyte counts and progression types

BACKGROUND: In the Response Evaluation Criteria for Solid Tumors (RECIST) diagnostic criteria, the concepts of progression by preexisting disease (PPL) and progression by new metastases (PNM) have been proposed to distinguish between the progression types of cancer refractory to treatment. According...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morisaki, Tamami, Kashiwagi, Shinichiro, Asano, Yuka, Goto, Wataru, Takada, Koji, Ishihara, Sae, Shibutani, Masatsune, Tanaka, Hiroaki, Hirakawa, Kosei, Ohira, Masaichi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8591927/ https://www.ncbi.nlm.nih.gov/pubmed/34775950 http://dx.doi.org/10.1186/s12957-021-02441-w

Ejemplares similares

Clinical verification of body mass index and tumor immune response in patients with breast cancer receiving preoperative chemotherapy
por: Takada, Koji, et al.
Publicado: (2021)

Inhibitory effects of iron depletion plus eribulin on the breast cancer microenvironment
por: Goto, Wataru, et al.
Publicado: (2020)

Differences in tumor-infiltrating lymphocyte density and prognostic factors for breast cancer by patient age
por: Takada, Koji, et al.
Publicado: (2022)

Prediction of distant metastatic recurrence by tumor-infiltrating lymphocytes in hormone receptor-positive breast cancer
por: Takada, Koji, et al.
Publicado: (2021)

Study on the progression types of cancer in patients with breast cancer undergoing eribulin chemotherapy and tumor microenvironment
por: Kashiwagi, Shinichiro, et al.
Publicado: (2018)

Prediction of lymph node metastasis by tumor-infiltrating lymphocytes in T1 breast cancer
por: Takada, Koji, et al.
Publicado: (2020)

The effect of smoking on biological change of recurrent breast cancer
por: Takada, Koji, et al.
Publicado: (2020)

Pathological Complete Response following Neoadjuvant Chemotherapy in Invasive Ductal Carcinoma with Mammary Paget's Disease: A Case Report
por: Goto, Wataru, et al.
Publicado: (2021)

Identification of predictive markers of the therapeutic effect of eribulin chemotherapy for locally advanced or metastatic breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2017)

Novel evaluation scale for QOL (QOL-ACD-BP) in preoperative chemotherapy for breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Use of Tumor-infiltrating lymphocytes (TILs) to predict the treatment response to eribulin chemotherapy in breast cancer
por: Kashiwagi, Shinichiro, et al.
Publicado: (2017)

Predicting therapeutic efficacy of endocrine therapy for stage IV breast cancer by tumor-infiltrating lymphocytes
por: Asano, Yuka, et al.
Publicado: (2020)

Breast Angiosarcoma with a Preoperative Diagnosis of Late Recurrence of Breast Cancer: A Case Report
por: Kouhashi, Rika, et al.
Publicado: (2021)

Clinical verification of the relationship between serum lipid metabolism and immune activity in breast cancer patients treated with neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2023)

Factors predictive of invasive ductal carcinoma in cases preoperatively diagnosed as ductal carcinoma in situ
por: Takada, Koji, et al.
Publicado: (2020)

Prediction of treatment responses to neoadjuvant chemotherapy in triple-negative breast cancer by analysis of immune checkpoint protein expression
por: Asano, Yuka, et al.
Publicado: (2018)

Adenoid Cystic Carcinoma of the Breast: A Case Report
por: Kashiwagi, Shinichiro, et al.
Publicado: (2019)

Cowden Syndrome Diagnosed by Bilateral Breast Cancer with Lhermitte-Duclos Disease: A Case Report
por: Morisaki, Tamami, et al.
Publicado: (2020)

Expression and Clinical Significance of Androgen Receptor in Triple-Negative Breast Cancer
por: Asano, Yuka, et al.
Publicado: (2017)

Impact of oral statin therapy on clinical outcomes in patients with cT1 breast cancer
por: Takada, Koji, et al.
Publicado: (2023)

Use of the tumor-infiltrating CD8 to FOXP3 lymphocyte ratio in predicting treatment responses to combination therapy with pertuzumab, trastuzumab, and docetaxel for advanced HER2-positive breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Significance of intrinsic breast cancer subtypes on the long-term prognosis after neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)

Clinical verification of the relationship between smoking and the immune microenvironment of breast cancer
por: Takada, Koji, et al.
Publicado: (2019)

Verification of the effects of calcium channel blockers on the immune microenvironment of breast cancer
por: Takada, Koji, et al.
Publicado: (2019)

Possibility of avoiding axillary lymph node dissection by immune microenvironment monitoring in preoperative chemotherapy for breast cancer
por: Takada, Koji, et al.
Publicado: (2018)

Sorafenib inhibits vascular endothelial cell proliferation stimulated by anaplastic thyroid cancer cells regardless of BRAF mutation status
por: Ishihara, Sae, et al.
Publicado: (2019)

Predictive value of lymphocyte-to-monocyte ratio in the preoperative setting for progression of patients with breast cancer
por: Goto, Wataru, et al.
Publicado: (2018)

A comparison of the local immune status between the primary and metastatic tumor in colorectal cancer: a retrospective study
por: Shibutani, Masatsune, et al.
Publicado: (2018)

Alveolar soft part sarcoma metastatic to the breast: a case report
por: Asano, Yuka, et al.
Publicado: (2019)

Continuous intraoperative neuromonitoring for thyroid cancer surgery: A prospective study
por: Onoda, Naoyoshi, et al.
Publicado: (2019)

Significance of re-biopsy for recurrent breast cancer in the immune tumour microenvironment
por: Takada, Koji, et al.
Publicado: (2018)

Predictive value of improvement in the immune tumour microenvironment in patients with breast cancer treated with neoadjuvant chemotherapy
por: Goto, Wataru, et al.
Publicado: (2018)

Circulating tumor cell clusters-associated gene plakoglobin is a significant prognostic predictor in patients with breast cancer
por: Goto, Wataru, et al.
Publicado: (2017)

A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections
por: Iseki, Yasuhito, et al.
Publicado: (2018)

Severe pancytopenia caused by trifluridine/tipiracil in patients with metastatic colorectal cancer and an impaired renal function: A case report
por: Shibutani, Masatsune, et al.
Publicado: (2022)

The peripheral monocyte count is associated with the density of tumor-associated macrophages in the tumor microenvironment of colorectal cancer: a retrospective study
por: Shibutani, Masatsune, et al.
Publicado: (2017)

Abundant intratumoral fibrosis prevents lymphocyte infiltration into peritoneal metastases of colorectal cancer
por: Wang, En, et al.
Publicado: (2021)

Prediction of survival after neoadjuvant chemotherapy for breast cancer by evaluation of tumor-infiltrating lymphocytes and residual cancer burden
por: Asano, Yuka, et al.
Publicado: (2017)

Multiple metastatic malignant phyllodes tumor of the breast with tonsillar metastasis: a case report
por: Sera, Tomohiro, et al.
Publicado: (2017)

The significance of the C-reactive protein to albumin ratio as a marker for predicting survival and monitoring chemotherapeutic effectiveness in patients with unresectable metastatic colorectal cancer
por: Shibutani, Masatsune, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_lt4ctof7ufscfmtasbgl1uj0pi